Tumor growth of both cell lines was dramatically reduced in cblb-deficient animals demonstrating that genetic ablation of Cbl-b provokes the ability to reject or attenuate growths of weak and highly immunogenic tumors independent of CD28-co-stimulation of effector cells. Here, CBLB is linked to neoplasm.